Literature DB >> 23009725

Challenging deprotection steps during the synthesis of tetra- and pentasaccharide fragments of the Le(a)Le(x) tumor-associated hexasaccharide antigen.

Mickaël Guillemineau1, France-Isabelle Auzanneau.   

Abstract

We report the convergent synthesis of two novel tetrasaccharide and two novel pentasaccharide fragments of the Le(a)Le(x) TACA: the tetrasaccharides contain neither the galactose at the Le(a) nonreducing end nor the fucose at the Le(x) reducing end; the pentasaccharides only lack the galactose residue at the Le(a) nonreducing end. Two of the analogues were prepared as hexyl glycosides to be used in NMR experiments and as soluble inhibitors in binding studies and two as 6-aminohexyl glycosides to be conjugated to carrier proteins. Our strategy relied on stepwise extensions using excess monosaccharide glycosyl donors (trichloroacetimidates and thioglycosides) in sequential glycosylation reactions. The protecting groups were chosen to limit the number of deprotection steps required to obtain the final derivatives. While this strategy ensured that all glycosylation reactions proceeded in very good yields (70-84%), deprotection of the oligosaccharide intermediates was challenging. Global deprotection using Birch metal dissolving conditions did not remove the tert-butyldiphenylsilyl group, which indeed was incompatible with such reaction conditions. Attempts to remove the TBDPS with tetrabutylammonium fluoride was unsuccessful and led to a complex mixture of compounds that could not be separated. The desired hexyl and aminohexyl tetrasaccharides were finally obtained after four- and five-step deprotection sequences, respectively. Deprotection of the pentasaccharide intermediate to give the hexyl and aminohexyl analogues also led to unexpected results. Indeed, during Zemplén deacylation, a chloroacetamide chlorine atom was displaced by methoxide ions leading to the corresponding methoxyacetamide. Once the chloroacetamide was fully reduced to an acetamide the pentasaccharides were obtained in four and five steps, respectively.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23009725     DOI: 10.1021/jo301644w

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  6 in total

1.  Two-step functionalization of oligosaccharides using glycosyl iodide and trimethylene oxide and its applications to multivalent glycoconjugates.

Authors:  Hsiao-Wu Hsieh; Ryan A Davis; Jessica A Hoch; Jacquelyn Gervay-Hague
Journal:  Chemistry       Date:  2014-04-08       Impact factor: 5.236

2.  Mapping the Reactivity and Selectivity of 2-Azidofucosyl Donors for the Assembly of N-Acetylfucosamine-Containing Bacterial Oligosaccharides.

Authors:  Bas Hagen; Sara Ali; Herman S Overkleeft; Gijsbert A van der Marel; Jeroen D C Codée
Journal:  J Org Chem       Date:  2017-01-10       Impact factor: 4.354

3.  Orthogonal protection of saccharide polyols through solvent-free one-pot sequences based on regioselective silylations.

Authors:  Serena Traboni; Emiliano Bedini; Alfonso Iadonisi
Journal:  Beilstein J Org Chem       Date:  2016-12-14       Impact factor: 2.883

4.  Defining the SN1 Side of Glycosylation Reactions: Stereoselectivity of Glycopyranosyl Cations.

Authors:  Thomas Hansen; Ludivine Lebedel; Wouter A Remmerswaal; Stefan van der Vorm; Dennis P A Wander; Mark Somers; Herman S Overkleeft; Dmitri V Filippov; Jérôme Désiré; Agnès Mingot; Yves Bleriot; Gijsbert A van der Marel; Sebastien Thibaudeau; Jeroen D C Codée
Journal:  ACS Cent Sci       Date:  2019-04-18       Impact factor: 14.553

5.  Exploratory N-Protecting Group Manipulation for the Total Synthesis of Zwitterionic Shigella sonnei Oligosaccharides.

Authors:  Debashis Dhara; Laurence A Mulard
Journal:  Chemistry       Date:  2021-03-01       Impact factor: 5.236

6.  Total Synthesis of Tri-, Hexa- and Heptasaccharidic Substructures of the O-Polysaccharide of Providencia rustigianii O34.

Authors:  Somayeh Ahadi; Shahid I Awan; Daniel B Werz
Journal:  Chemistry       Date:  2020-04-28       Impact factor: 5.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.